Searchable abstracts of presentations at key conferences in endocrinology

ea0035p515 | Endocrine tumours and neoplasia | ECE2014

Our experience in the evaluation criteria used for the genetic study of patients suspected of being affected by multiple endocrine neoplasia type 1 and mutational spectrum

Oriola Josep , Sitges Antoni , Goday Albert , Martinez S , Villabona Carles , Gomez Jose Manuel , Loidi Lourdes , Salinas Isabel , Puig-Domingo Manel , Gonzalez-Romero E , Garcia-Arnes J A , Lecube Albert , Mesa Jordi , Simo Rafael , Rosell J , Sanchez-Garcia F , Recas Immaculada , Biarnes Josefina , Pizarro Eduarda , Halperin Irene

Introduction: The autosomal dominant multiple endocrine neoplasia type 1 (MEN1), characterized by parathyroid hyperplasia (PH), neuroendocrine digestive tumours (NET) and pituitary adenomas (PA), is due to mutations in the tumor suppressor gene MEN1 encoding a 610-amino acid protein, menin. Guidelines recommend MEN1 mutational analysis in index cases with two or more MEN1-associated tumours, in first-degree relatives of mutation carriers and when clinical dat...

ea0090p111 | Endocrine-related Cancer | ECE2023

Body composition of Patients with advanced Gastroenteropancreatic (GEP) Neuroendocrine Neoplasms (NENs) in Spain: Nutrigetne Study

Argente Pla Maria , Casteras Anna , Giribes Miguel , Anton Beatriz , Soledad Librizzi Maria , Custodio Carretero Ana , Palma Milla Samara , Suarez Gutierrez Lorena , Peiro Inmaculada , Serrano Urzaiz Leticia , Leon-Idougourram Soraya , Dieguez Felechosa Marta , Febrero Beatriz , Scorojanu Iulia , Antonio Pazos Toral Fernando , Biarnes Josefina , Pascual-Corrales Eider , Angel Dias-Perez Jose , Antonio Sampedro-Nunez Miguel , Angel Martinez Olmos Miguel , Mico Garcia Andrea , Isabel Del Olmo Garcia Maria

Introduction / Background: Patients with advanced GEP-NENs often present with metabolic disorders and oncological treatments may increase malnutrition risk as well as alterations on body composition. Several studies have suggested that sarcopenia is independently associated with a worse prognosis in oncological patients. Sarcopenia predicts survival regardless of body weight; moreover, a reduced muscle mass is not only observed in cachectic individuals but also in overweight p...